arrow_back Back Filing freshness 10-Q Q1 FY2026 SEC EDGAR

SS Innovations International, Inc.

SSII
$3.74 ▼ -0.07 (-1.84%) at close
Healthcare ·Surgical & Medical Instruments & Apparatus ·USSurgical & Medical Instruments & Apparatus
41 Visible periods
26 Metrics
Peer-ranked Benchmarks
Price Chart
25
Health
Poor
Bearish
auto_awesome

Analytical Summary

SS Innovations International, Inc. faces fundamental challenges with weakness in Return on Common Equity (%) and Profit Margin (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $733.1M
Dividend Yield
Revenue Growth 116.8%
Op. Margin -32.8%
ROIC -7.0%
FCF / Share $-0.01
Trailing P/E
Price / Book 13.7x
FCF Yield
Debt / Equity
info Valuation on last close. End-of-day price, Aug 7, 2026.

41-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$11.10M
↑ +116.8%
Net Income Profit after all expenses
$-3.58M
↑ +36.9%
Operating Margin Operating profit as % of sales
-32.8%
↓ -548.2% 10th
FCF / Share Free cash flow per share
$-0.01
↑ +69.1%
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Operating Margin (%)Operating Margin (%) is in the bottom quartile
  • Profit Margin (%)Profit Margin (%) is in the bottom quartile
  • Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Profitability
8
Returns
22
Financial Health
21
Cash Quality
84

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 11 years · 41 quarters